The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 5,137,150 | 635,000 | SH | SOLE | 635,000 | 0 | 0 | |||
| ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 1,624,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 3,587,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 30,225,400 | 790,000 | SH | SOLE | 790,000 | 0 | 0 | |||
| ALLAKOS INC | COM | 01671P100 | 8,455,000 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | |||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 10,229,000 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | |||
| AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 42,846,747 | 4,803,447 | SH | SOLE | 4,803,447 | 0 | 0 | |||
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 14,605,000 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | |||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 9,067,322 | 590,705 | SH | SOLE | 590,705 | 0 | 0 | |||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 47,371,385 | 6,579,359 | SH | SOLE | 6,579,359 | 0 | 0 | |||
| CABALETTA BIO INC | COM | 12674W109 | 15,175,450 | 1,835,000 | SH | SOLE | 1,835,000 | 0 | 0 | |||
| CELCUITY INC | COM | 15102K100 | 14,255,413 | 1,390,772 | SH | SOLE | 1,390,772 | 0 | 0 | |||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 17,839,712 | 495,823 | SH | SOLE | 495,823 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 51,494,423 | 4,772,421 | SH | SOLE | 4,772,421 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 17,658,000 | 2,025,000 | SH | SOLE | 2,025,000 | 0 | 0 | |||
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 9,889,268 | 739,661 | SH | SOLE | 739,661 | 0 | 0 | |||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 156,641 | 92,687 | SH | SOLE | 92,687 | 0 | 0 | |||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 8,785,711 | 217,253 | SH | SOLE | 217,253 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 37,916,894 | 1,731,365 | SH | SOLE | 1,731,365 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 22,349,894 | 1,440,999 | SH | SOLE | 1,440,999 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,456,667 | 312,553 | SH | SOLE | 312,553 | 0 | 0 | |||
| KURA ONCOLOGY INC | COM | 50127T109 | 14,736,636 | 1,204,958 | SH | SOLE | 1,204,958 | 0 | 0 | |||
| MERUS N V | COM | N5749R100 | 54,280,000 | 2,950,000 | SH | SOLE | 2,950,000 | 0 | 0 | |||
| NUVALENT INC | COM | 670703107 | 28,046,750 | 1,075,000 | SH | SOLE | 1,075,000 | 0 | 0 | |||
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 13,646,382 | 127,156 | SH | SOLE | 127,156 | 0 | 0 | |||
| REZOLUTE INC | COM NEW | 76200L309 | 1,724,673 | 898,267 | SH | SOLE | 898,267 | 0 | 0 | |||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 18,034,030 | 853,884 | SH | SOLE | 853,884 | 0 | 0 | |||
| THIRD HARMONIC BIO INC | COM | 88427A107 | 4,092,371 | 993,294 | SH | SOLE | 993,294 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 7,496,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 21,914,465 | 2,824,029 | SH | SOLE | 2,824,029 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 55,704,925 | 2,189,659 | SH | SOLE | 2,189,659 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 66,032,550 | 1,845,000 | SH | SOLE | 1,845,000 | 0 | 0 | |||